AJ

Asa Jyothi Poluri

Active Director Director DIN 08222461
DIN 08222461 First appointment Sep 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Asa Jyothi Poluri

Data last updated:

Asa Jyothi Poluri is a Director at Themicure Pharmaceuticals Private Limited (since 2018). The company operates in Chemicals. Themicure Pharmaceuticals Private Limited reported revenue of ₹6.7 Lakh (FY 2025).

DIN 08222461
Primary Designation Director
Industry Chemicals
First Appointment 12 Sep 2018
Oldest Company Age 8 yrs
Largest company Themicure Pharmaceuticals Private Limited · ₹6.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Sep 20182018₹6.7 Lakh (FY 2025)Active

Board colleagues of Asa Jyothi Poluri

Directorship timeline

Open interactive timeline →
Themicure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Asa Jyothi Poluri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asa Jyothi Poluri

Asa Jyothi Poluri currently holds 1 directorship: Themicure Pharmaceuticals Private Limited (Director, since 12 Sep 2018, revenue ₹6.7 Lakh (FY 2025)).

Asa Jyothi Poluri was first appointed on 12 Sep 2018 as Director at Themicure Pharmaceuticals Private Limited.

The current boards of Asa Jyothi Poluri's companies include Lakshmi Pardhasaradhi Kandukuri (Themicure Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available